I agree that management have been very good at managing expectations. This was a solid result explained in part by higher margin in arhi business as a result of lower than expected claims growth, with claims inflation currently at historical lows.
I would be interested in your thoughts on what you consider to be a good buying opportunity in the coming months. Looking expensive at current levels given consensus price target $6.00 (10 analysts). Trading on a PE around 25 which does not appear commensurate with forecast EPS Growth.
NHF Price at posting:
$6.58 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
